SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-029979
Filing Date
2022-10-31
Accepted
2022-10-31 16:11:43
Documents
16
Period of Report
2022-10-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 50772
2 ex10-1.htm EX-10.1 132521
3 ex99-1.htm EX-99.1 13391
4 ex99-1_001.jpg GRAPHIC 3819
  Complete submission text file 0001493152-22-029979.txt   453651

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE bfri-20221025.xsd EX-101.SCH 4288
6 XBRL DEFINITION FILE bfri-20221025_def.xml EX-101.DEF 27600
7 XBRL LABEL FILE bfri-20221025_lab.xml EX-101.LAB 38253
8 XBRL PRESENTATION FILE bfri-20221025_pre.xml EX-101.PRE 26217
10 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 6875
Mailing Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801
Business Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801 781-245-1325
Biofrontera Inc. (Filer) CIK: 0001858685 (see all company filings)

IRS No.: 473765675 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40943 | Film No.: 221346101
SIC: 2834 Pharmaceutical Preparations